SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
867.00    15.00 (1.76%)
Bid:
867.00
Ask:
873.00
Spread: 6.00 (0.692%)
Market Cap: £515.62m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Q3 2025 Trading Update

18 Nov 2025 07:00

RNS Number : 8879H
Pollen Street Group Limited
18 November 2025
 

18 November 2025

Pollen Street Group Limited Q3 2025 Trading Update

Continued AuM Expansion Driven by Robust Fundraising and Deployment

Pollen Street Group Limited ("Pollen Street", together with its subsidiaries, the "Group") today issues its trading update for the period ended 30 September 2025. The Group continues to deliver strong progress in fundraising and deployment across both Private Credit and Private Equity strategies, underpinning its medium-term growth trajectory.

Asset under Management

· Total AuM reached £6.7 billion as at 30 September 2025, up 9.9% from £6.1 billion at 30 June 2025 and up 32.0% from Q3 2024 (September 2024: £5.1 billion).

 

· Fee-paying AuM increased to £5.1 billion as at 30 September 2025, up 9.7% from £4.7 billion at 30 June 2025 and up 41.7% from Q3 2024 (September 2024: £3.6 billion).

Growth in fee-paying AuM reflected strong deployment in Private Credit and in Private Equity as well as the final close of Private Equity Fund V in the period.

Private Credit

Pollen Street's differentiated Private Credit strategy continues to perform strongly, with sustained investor demand and high levels of deployment into asset-based lending opportunities. Six new transactions were completed during Q3. Borrower commitments increased to £2.7 billion as at 30 September 2025, up from £2.4 billion at 30 June 2025, while drawn balances grew by £0.3 billion to £2.0 billion, reflecting strong origination and deployment momentum.

Private Credit Fund IV continues to attract strong investor interest. Following the most recent close in November, total fund commitments have now surpassed the original target raise and stand at £1.1 billion. We continue to progress well in diligence with investors that we expect to close into the fund, ahead of a final close in Q1 2026.

Private Equity

Pollen Street's Private Equity strategy also maintained its momentum in Q3, focusing on disciplined execution across new investments, value creation and portfolio optimisation. During the period, the team completed the acquisition of Leonard Curtis, a leading UK corporate restructuring services platform, as a new investment in Private Equity Fund V, and the sale of Kingswood UK to Mattioli Woods, representing a partial disposal from Fund III.

Portfolio expansion continued through several strategic bolt-on acquisitions for Aryza, Assessio and Pivotal Growth.

The pace of deployment in Private Equity Fund V, which held its final close in July 2025 at €1.5 billion, continues in line with expectations with a strong pipeline of both new investments and portfolio bolt-on acquisitions.

Investment Company

· The Investment Company generated an annualised net investment return of 8.4% for the year-to-date. This represents an underlying 9.1% portfolio return before the effect of temporary equalisation adjustments (where gains are reallocated between investors as if they had all come in at first close).

 

· As at 30 September 2025, Net Investment Assets stood at £331 million up from £319 million as at 30 June 2025.

Outlook

Pollen Street continues to accelerate fundraising momentum, supported by a deep and diversified investor base, high-performing strategies, and sustained market demand for private capital solutions. The Group is progressing well towards its medium-term AuM target of £10 billion, driven by continued scaling in fundraising and deployment across both strategies, and continues to trade in line with expectations.

Private Credit Teach-in

Pollen Street will host a Private Credit Teach-In for analysts and institutional investors in London on 24 November 2025. Please contact shareholders@pollencap.com if you wish to attend. A recording of the event will also be made available on the Group's website following the presentation.

About Pollen Street

Pollen Street is an alternative asset manager dedicated to investing within the financial and business services sectors across both Private Equity and Private Credit strategies. Founded in 2013, the Group has consistently delivered top-tier returns alongside growing AuM.

Pollen Street operates through two complementary segments: the Asset Manager, which manages third-party AuM, and the Investment Company, which invests on balance sheet to generate attractive returns and accelerate AuM growth through alignment with investors.

POLN is listed on the London Stock Exchange (ticker symbol: POLN) and is a member of the FTSE 250 index. Further details are available at www.pollenstreetgroup.com

For further information about this announcement please contact:

Pollen Street - Corporate Development Director

Shweta Chugh

+44 (0)20 3965 5081

 

Barclays Bank plc - Joint Broker

Neal West / Stuart Muress

+44 (0)20 7623 2323

 

Investec Bank plc - Joint Broker

Ben Griffiths / Kamalini Hull

+44 (0)20 7597 4000

 

FGS Global

Chris Sibbald / Anna Tabor

PollenStreetCapital-LON@fgsglobal.com

 

MUFG Corporate Governance Limited - Company Secretary

POLNcosec@cm.mpms.mufg.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKOBBDBDBQDD
Date   Source Headline
1st Jun 20263:01 pmRNSTotal Voting Rights
27th May 20264:46 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:39 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSQ1 2026 Trading Update
6th May 20264:40 pmRNSDirector/PDMR Shareholding
1st May 20269:49 amRNSTotal Voting Rights
1st May 20268:12 amRNSResult of AGM
28th Apr 20264:31 pmRNSDirector/PDMR Shareholding
16th Apr 20265:31 pmRNSInvestor Presentation via Investor Meet Company
14th Apr 20267:00 amRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
27th Mar 202610:36 amRNSDirector/PDMR Shareholding
26th Mar 20264:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:30 amRNSDividend Declaration
26th Mar 20267:00 amRNSFull Year 2025 Trading Update
2nd Mar 202611:26 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20261:57 pmRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:32 pmRNSDirector/PDMR Shareholding
2nd Feb 20263:12 pmRNSTotal Voting Rights
30th Jan 202610:59 amRNSDirectorate changes
28th Jan 202611:37 amRNSDirector/PDMR Shareholding
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSDirectorate change
23rd Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20254:27 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20259:50 amRNSUpdate Statement on 2025 AGM Voting Results
1st Dec 202511:15 amRNSTotal Voting Rights
28th Nov 20256:23 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSQ3 2025 Trading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSAnnouncement of New Share Buyback Programme
16th Oct 20256:16 pmRNSHolding(s) in Company
3rd Oct 202511:32 amRNSDirector/PDMR Shareholding
1st Oct 20255:12 pmRNSDirector/PDMR Shareholding
30th Sep 20254:07 pmRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.